Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Mutations of the p53 gene are one of the most frequent genomic alterations of human tumours of astrocytic lineage. Because the physiological role of this gene is a suppression of cellular proliferation and growth, the overexpression of p53-protein may correlate with the expression of PCNA or Ki-67, established markers of cell proliferation. Paraffin-embedded surgical specimens from 60 human astrocytomas (9 pilocytic tumours, 12 WHO grade II, 9 anaplastic astrocytomas [WHO grade III] and 30 glioblastomas [WHO grade IV]) were stained with anti-PCNA (PC10), anti-p53(DO-7) and anti-Ki-67 antibodies (DAKO). Approximately 40% of all the cases were p53-protein immunopositive (53.3% glioblastomas, 33.3% anaplastic, 41.7% low grade astrocytomas but no pilocytic tumor). Statistical analysis did not reveal statistically significant correlation between p53-immunopositivity and PCNA or Ki-67 labeling indices. The Ki-67- and PCNA LI-s were statistically correlated, and the former better discriminated groups of different grades of malignancy.
Kordek
R
R
Department of Oncology, Medical University of Lodz, Poland.
Biernat
W
W
Debiec-Rychter
M
M
Alwasiak
J
J
Liberski
P P
PP
D000951:Antigens, Neoplasm / Q000032:analysis; D001254:Astrocytoma / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis; D001932:Brain Neoplasms / Q000276:immunology*; D002455:Cell Division / Q000276:immunology; D005909:Glioblastoma / Q000276:immunology; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis*; D008940:Mitotic Index / Q000276:immunology*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis* / Q000096:biosynthesis; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis*
D000951:Antigens, Neoplasm; D015415:Biomarkers; D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D016159:Tumor Suppressor Protein p53